The hollow fibre model in cancer drug screening: The NCI experience

European Journal of Cancer

Volumn 40, Issue 6, 2004, Pages 821-826

  Decker, S ^a   Hollingshead, M ^a   Bonomi, C A ^b   Carter, J P ^b   Sausville, E A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Drug discovery; Drug screening; Hollow fibre; In vivo models

Indexed keywords

ANTINEOPLASTIC AGENT;

CELL LINE; DECISION MAKING; DRUG EFFICACY; DRUG SCREENING; HOLLOW FIBER; HUMAN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; XENOGRAFT;

EID: 1942518907     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.11.029     Document Type: Article

References (9)

1. Monks A., Scudiero D., Skehan P.et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83:1991;757-766.
2. Paull K.D., Shoemaker R.H., Hodes L.et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines. development of the mean graph and COMPARE algorithm J. Natl. Cancer Inst. 81:1989;1088-1092.
3. Hollingshead M.G., Alley M.C., Camalier R.F.et al. In vivo cultivation of tumor cells in hollow fibers. Life Sci. 57:1995;131-141.
4. Johnson J.I., Decker S., Zaharevitz D.et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Brit. J. Cancer. 84:2001;1424-1431.
5. Phillips R.M., Pearce J., Loadman P.M.et al. Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells. implications for anticancer drug screening programs Cancer Res. 58:1998;5263-5266.
6. Hall L.A., Krauthauser C.M., Wexler R.S., Hollingshead M.G., Slee A.M., Kerr J.S. The hollow fiber assay. continued characterization with novel approaches Anticancer Res. 20:2000;903-911.
7. Alley M.C., Pacula-Cox C.M., Hursey M.L., Rubinstein L.R., Boyd M.F. Morphometric and colorimetric analyses of human tumor cell line growth and drug sensitivity in soft agar culture. Cancer Res. 51:1991;1247-1256.
8. Sausville E.A., Feigal E. Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA. Ann. Oncol. 10:1999;1287-1291.
9. Hollingshead M.G., Bonomi C.A., Borgel S.D.et al. A potential role for imaging technology in anticancer efficacy evaluations. Eur. J. Cancer. 40:2004;6. this issue.